A Closer Look at Intellia Therapeutics's Options Market Dynamics
Portfolio Pulse from Benzinga Insights
Intellia Therapeutics (NASDAQ:NTLA) has seen significant bearish options activity, with 89% of trades being puts. This suggests that large investors expect the stock price to fall, targeting a range of $17.5 to $20.0. The stock is currently down 12.24% to $17.5, and its RSI indicates it may be oversold.

October 24, 2024 | 6:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intellia Therapeutics has experienced unusual bearish options activity, with 89% of trades being puts. This indicates that large investors expect the stock price to decrease, targeting a range of $17.5 to $20.0. The stock is currently down 12.24% to $17.5, and its RSI suggests it may be oversold.
The significant bearish options activity, with 89% of trades being puts, suggests that large investors are expecting a decline in Intellia's stock price. The current price drop of 12.24% to $17.5 aligns with this sentiment. Additionally, the RSI indicates the stock may be oversold, which could lead to further price volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100